Esperion Therapeutics reported $33.73M in Trade Debtors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Alnylam Pharmaceuticals ALNY:US USD 237.96M 53.45M
Amarin AMRN:US USD 123.38M 20.56M
Amgen AMGN:US USD 5.56B 237M
Biogen BIIB:US USD 2.14B 152.2M
Biomarin Pharmaceutical BMRN:US USD 461.32M 41.69M
Cytokinetics CYTK:US USD 147K 2.15M
Daiichi Sankyo 4568:JP JPY 355.36B 21.86B
Esperion Therapeutics ESPR:US USD 33.73M 2.24M
Geron GERN:US USD 3.14M 19.08M
Halozyme Therapeutics HALO:US USD 231.07M 2.23M
Heron Therapeutics HRTX:US USD 42.19M 1.88M
Intercept Pharmaceuticals ICPT:US USD 26.86M 694K
Intra Cellular Therapies ITCI:US USD 75.19M 13.65M
Moderna Inc MRNA:US USD 1.63B 1.19B
Nektar Therapeutics NKTR:US USD 5.98M 5.55M
Ptc Therapeutics PTCT:US USD 155.61M 31.16M
Puma Biotechnology PBYI:US USD 42.27M 10.39M
Regeneron Pharmaceuticals REGN:US USD 5.33B 219.6M
Sarepta Therapeutics SRPT:US USD 259.7M 36.25M
Seattle Genetics SGEN:US USD 501.91M 15.16M
United Therapeutics UTHR:US USD 220.4M 11.3M
Vanda Pharmaceuticals VNDA:US USD 33.51M 4.16M